SK Capital Partners has agreed to acquire LISI Group’s medical division, LISI Medical, a contract development and manufacturing organization specializing in components used by medical device OEMs.
LISI Medical produces high-precision metal components and assemblies for medical device OEMs, including surgical instruments for minimally invasive procedures and orthopedic implants.
LISI Medical operates in the medical device contract manufacturing industry which is growing due to demand for minimally invasive procedures, and is projected to reach $146 billion by 2030.
The transaction, expected to close before the end of 2025, is set to accelerate LISI Medical's growth through expansion with existing and new customers, new capabilities, and potentially through M&A.